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hysterectomy for heavy menstrual bleeding. The structure of the model was represented graphically.
Outcomes assessed in the review
The outcomes estimated from the literature were: the probabilities of surgical complications for hysterectomy, odds ratio (ORs) of surgical complications in ER/A versus hysterectomy, the yearly probability of additional surgery for menorrhagia, the duration of convalescence post-surgery, the duration of hospitalisation, and the utility values.
Study designs and other criteria for inclusion in the review
The primary studies were identified from two published meta-analyses, the inclusion criteria for which were studies on first-or second-generation techniques (e.g. trans-cervical resection of endometrium, endometrial ablation by electrocautery, laser or balloon therapy) for ER/A and studies on abdominal, vaginal, laparoscopic or laparoscopicallyassisted vaginal routes for hysterectomy. Medical regimens included were LNG-IUS and oral medical therapy (nonsteroidal anti-inflammatory agents, tranexamic acid, oral contraceptive pills, progestogens and danazol). Yearly rates of additional surgeries were obtained from 10 clinical trials, while the rate of surgical complications was obtained from 4 clinical trials. The utility values were derived from a study based on interviews with patients.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
The use of clinical trials should have ensured a high internal validity of the primary studies.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Fourteen primary studies provided the clinical data and utility values.
Methods of combining primary studies
The primary estimates were combined by meta-analysis.
Investigation of differences between primary studies
Results of the review
The probabilities of surgical complications in hysterectomy were as follows:
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Methods used to derive estimates of effectiveness
The authors made some assumptions that were used in the decision model.
Estimates of effectiveness and key assumptions
The duration between the beginning of each cycle and additional surgery if needed was 6 months.
The utility value associated with convalescence post-surgical intervention was 0.65 (range: 0.55 to 0.95).
Measure of benefits used in the economic analysis
The summary benefit measure used was the total number of quality-adjusted life-years (QALYs) associated with the four treatments. QALYs were calculated by combining utility values for specific conditions with the time spent in those conditions. Both types of data were derived from the literature. No discount rate appears to have been applied to the health benefits.
The analysis of the costs was carried out from the perspective of a health service provider. It included the costs associated with the primary treatment options, treatment of surgical complications, and additional hysterectomy in case of primary treatment failure. The unit costs and the quantities of resources used were not presented separately. The costs were mainly presented as macro-categories. The source of resource consumption was unclear, while the costs came from charges for the health care services of public hospitals and clinics posted in the Hong Kong Gazette. Details of how the costs were calculated from charges were reported. Discounting was relevant, as 5-year costs were estimated, and an annual rate of 3% was applied. The price year was not reported.
Statistical analysis of costs
The costs were treated deterministically in the base-case.
Indirect Costs
The indirect costs were not considered.
Currency

US dollars ($).
Sensitivity analysis
A univariate sensitivity analysis was carried out to examine the robustness of the model results to variations in all inputs and to identify potentially influential factors. In particular, the probabilities of surgical complications, duration of hospitalisation and convalescence period for abdominal, vaginal and laparoscopic hysterectomy were examined over a broad range of values. Published ranges and confidence intervals were used. A probabilistic sensitivity analysis was also performed to evaluate the impact of uncertainty in all variables simultaneously using Monte Carlo simulation, in which the costs and QALYs were assigned triangular distributions.
Estimated benefits used in the economic analysis
The total QALYs were 4.625 with LNG-IUS, 4.575 with oral medical treatment, 4.624 with ER/A and 4.725 with hysterectomy.
Cost results
The total costs per patient were $4,528 with LNG-IUS, $5,508 with oral medical treatment, $6,185 with ER/A and $6,878 with hysterectomy.
Synthesis of costs and benefits
Average and incremental cost-utility ratios were calculated to combine the costs and benefits of the alternative treatments.
The average cost per QALY gained was $979 with LNG-IUS, $1,204 with oral medical treatment, $1,338 with ER/A and $1,456 with hysterectomy.
The incremental analysis showed that oral medical treatment and ER/A were both dominated by LNG-IUS, which was more effective and less expensive. The incremental cost per QALY gained with hysterectomy over LNG-IUS was $23,500.
The deterministic sensitivity analysis showed that hysterectomy remained the most cost-effective strategy in most scenarios. However, when the probability of need for extra surgery in the ER/A group was lower than 0.055, the ER/A group dominated both the oral medical treatment and the LNG-IUS groups, and the incremental cost per QALY gained with hysterectomy exceeded the threshold of $50,000.
